Hunting for Better Outcomes: Management Options for Huntington’s Disease
Huntington’s disease (HD) is a rare, progressive, genetic disorder resulting in a breakdown of nerve cells in the brain. Many types of clinicians are involved in the patient journey because HD affects movement, behavior, memory loss, impulse control, and the ability to do the simplest self-care activities. This multimedia activity provides the collaborative care team of neurologists, psychiatrists, and allied healthcare providers with an improved understanding of the fundamentals of HD, its chronic burden, and how to treat patients accordingly. Hunting for Better Outcomes provides HCPs with an enhanced understanding of HD and tools for improving overall patient outcomes.
Category
Format
Credits
  • ACCME (All Other)
  • ACCME (MD/DO Only)
  • ACPE Pharmacy
  • ANCC
Webcast: Screening, Diagnosis and Treatment of IDA in NDD-CKD
Iron deficiency anemia (IDA) is a common condition in patients with non–dialysis-dependent chronic kidney disease (NDD-CKD) that can affect quality of life and lead to suboptimal outcomes.
Category
  • CMHC
Format
  • Video
  • Webinar recorded
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
Webcast: Challenging Cases in NDD-CKD patients with IDA
Iron deficiency anemia (IDA) is the most common cause of anemia in patients with non–dialysis-dependent chronic kidney disease (NDD-CKD) and addressing this condition is important in the overall management of these patients.
Category
  • CMHC
Format
  • Video
  • Webinar recorded
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
A Closer Look: CDKL5 Deficiency Disorder & Rescue Treatment
Cyclin-dependent kinase-like 5 (CDKL5) deficiency disorder (CDD) is a rare developmental epileptic encephalopathy caused by mutations in the CDLK5 gene. The CDKL5 gene provides instructions for making proteins essential for normal brain and neuron development.
Category
Format
  • Book
Credits
  • ACCME (All Other)
  • ACCME (MD/DO Only)
  • ACPE Pharmacy
  • ANCC
17th Annual Cardiometabolic Health Congress On-Demand
Hundreds of practitioners gathered in Boston in October 2022 for the annual conference from Cardiometabolic Health Congress (CMHC).
Category
  • CMHC
Format
  • Conference / meeting
  • Video
Credits
  • ABIM MOC and AMA PRA Category 1 Credit
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
Virtual Symposium - Optimizing Lipid Lowering Therapy in Women: Gaps, Perspectives, and Advances
Atherosclerotic cardiovascular disease (ASCVD) events are among the leading causes of death in women in the US and globally.
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • Participation
Primer: Gamechangers in Alopecia Areata: Targeted Therapies for Patient-Centered Care
Currently, the standard of care for patients with alopecia areata (AA) is insufficient, challenging clinicians to find effective treatments in practice.
Category
  • LivDerm
  • TME
Format
  • Webinar recorded
Credits
  • AMA PRA Category 1 Credit
  • ANCC
  • Participation
Virtual Symposium - Assessing the Evolving Role of GLP1-RAs to Reduce Cardiovascular Risk: Emerging Evidence, Evolving Guidance, and Expert Perspectives
GLP-1 RAs have carved an important role in the management of patients with type 2 diabetes (T2D), not only in glycemic control, but also in reducing cardiovascular and renal risk.
Category
  • CMHC
Format
  • Video
Credits
  • ABIM MOC and AMA PRA Category 1 Credit
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation
Virtual Symposium: What You Need to Know About Optimizing Cardiorenal Outcomes with Novel NonSteroidal MRAs
During this recorded symposium from the 2022 American Heart Association (AHA), you will get a chance to:
Category
  • CMHC
Format
  • Video
Credits
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • Participation
Virtual Symposium - Escaping the Current Gaps in the Understanding and Treatment of CKD Anemia: Making Sense of Emerging Therapies
Anemia is a common comorbidity in patients with chronic kidney disease (CKD), and is associated with significant morbidity and impacts on quality of life.  The complicated pathophysiology of the condition and the disadvantages associated with current treatments are some of the major barriers that
Category
  • CMHC
Format
  • Video
Credits
  • ABIM MOC and AMA PRA Category 1 Credit
  • ACPE Pharmacy
  • AMA PRA Category 1 Credit
  • ANCC
  • CDE
  • Participation

Pages